The original success of Viagra undeniably transformed the drug landscape, but betting in companies strongly reliant on unbranded versions presents a complex picture. While early returns were significant, the cessation of patents and the emergence of discounted alternatives have diminished sales. Consequently, a thorough assessment of ongoing income